WebFeb 4, 2024 · Danaher's approach to Catalent values it at a significant premium, the report said, adding that unclear how Catalent will proceed or whether it is receptive to a takeover offer. A deal is not imminent. Both Danaher and Catalent did not immediately respond to a Reuters request for comment on the report. Danaher, which currently has a market ... WebFeb 6, 2024 · Life sciences company Danaher Corporation (NYSE:DHR) has expressed interest in acquiring the contract manufacturer Catalent (NYSE:CTLT), Bloomberg reported Saturday, citing people familiar with the matter.. According to the sources, the recent moves by the Washington-based company have valued Catalent at a significant premium.It is …
Danaher DHR Stock Price, Company Overview & News - Forbes
WebApr 10, 2024 · The most trusted brand in stock market news; Fatest intelligence & alerts; Active trader chat rooms; Option trade alerts; Only comprehensive mobile notifications solution WebFeb 6, 2024 · Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter.. Catalent’s shares rose almost 20% to … attr amyloidose
Catalent Inc. (NYSE: CTLT) Continues Its Downward Trend
WebFeb 4, 2024 · Both Danaher and Catalent did not immediately respond to a Reuters request for comment on the report. Danaher, which currently has a market capitalization of about $197 billion, bought privately-held biotech company Aldevron in an all-cash deal for about $9.6 billion in June 2024. (Reporting by Juby Babu in Bengaluru Editing by Marguerita … WebFeb 5, 2024 · The most trusted brand in stock market news; Fatest intelligence & alerts; Active trader chat rooms; Option trade alerts; Only comprehensive mobile notifications solution WebFeb 6, 2024 · Bloomberg News. Danaher’s overtures in recent months may not lead to a deal. New Jersey-based Catalent has market value of $10 billion. Life sciences company Danaher Corp. has expressed takeover … attr amyloidosis